lacosamide adroiq
extrovis eu ltd. - lacosamid - epilepsi - antiepileptika, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.
lacosamide "stada" 50 mg filmovertrukne tabletter
stada arzneimittel ag - lacosamid - filmovertrukne tabletter - 50 mg
lacosamide "krka" 50 mg filmovertrukne tabletter
krka d.d. novo mesto - lacosamid - filmovertrukne tabletter - 50 mg
lacosamide "zentiva" 50 mg filmovertrukne tabletter
zentiva k.s. - lacosamid - filmovertrukne tabletter - 50 mg
donacom 1178 mg pulver til oral opløsning, breve
viatris aps - glucosaminsulfat natriumchlorid - pulver til oral opløsning, breve - 1178 mg
dolenio 1,178 mg filmovertrukne tabletter
blue bio pharmaceuticals ltd. - glucosaminsulfat natriumchlorid - filmovertrukne tabletter - 1,178 mg
lacosamide "stada" 100 mg filmovertrukne tabletter
stada arzneimittel ag - lacosamid - filmovertrukne tabletter - 100 mg
lacosamide "stada" 150 mg filmovertrukne tabletter
stada arzneimittel ag - lacosamid - filmovertrukne tabletter - 150 mg
lacosamide "stada" 200 mg filmovertrukne tabletter
stada arzneimittel ag - lacosamid - filmovertrukne tabletter - 200 mg
lacosamide "medical valley" 50 mg filmovertrukne tabletter
medical valley invest ab - lacosamid - filmovertrukne tabletter - 50 mg